| Related Articles |
Guanfacine Hydrochloride Extended-Release for Attention Deficit Hyperactivity Disorder: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines
Book. 2018 03 07
Authors: Harricharan S, Adcock L
Abstract
Since this time, Guanfacine hydrochloride extended-release’s (GXR) role in attention-deficit/hyperactivity disorder (ADHD) therapy has continued to be studied. The aim of this review is to assist decision-makers and prescribers by evaluating the recently published evidence on the clinical effectiveness and cost-effectiveness of GXR for the treatment children and adolescents with ADHD. Clinical guidelines will also be examined.
PMID: 30329242
via https://www.ncbi.nlm.nih.gov/pubmed/30329242?dopt=Abstract